10 reports

Abstract: - Global Neglected Tropical Diseases Diagnosis Market to Reach $7.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Neglected Tropical Diseases Diagnosis estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$7.9 Billion by 2027, growing at aCAGR of 4% over...

  • Tropical Disease
  • Diagnostics
  • World
  • China
  • United States

The North America point of care diagnostics market is expected to grow from US$ 16,612.40 million in 2021 to US$ 38,702.11 million by 2028; it is estimated to grow at a CAGR of 12.8% from 2021 to 2028. Increasing product launches and product developments is to drive the market growth.The number of point-of-care testing has steadily...

  • Point Of Care Testing
  • North America
  • Drug Approval
  • Laboratory Revenue

The global point of care diagnostics market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027. Point-of-care testing (POCT) includes screening or diagnostic tests performed outside traditional laboratories. These tests are designed to be used at or near the site where...

  • Point Of Care Testing
  • World
  • North America
  • United States
  • India
  • APAC
  • HIV AIDS Prevalence
  • Chronic Disease Prevalence

North America ultra-low temperature freezer market is anticipated to reach US$ 313.19 million in 2027 from US$ 220.25 million in 2019. The market is projected to grow with a CAGR of 4.7% from 2019 to 2027. The growth of the North America ultra-low temperature freezer market is primarily attributed to the rising demand for blood and blood...

  • Biotechnology
  • Pharmaceutical
  • Infectious Disease
  • North America
  • Freezer Sales
  • Energy Consumption

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Chagas Disease - Pipeline Review, H1 2020, provides an overview of the Chagas Disease (Infectious Disease) pipeline landscape. Chagas disease or...

  • Autoimmune Disease
  • United States
  • Prescription Drug Sales
  • Medical Technology Density

Summary AnteoTech Ltd (AnteoTech) formerly Anteo Diagnostics Ltd is a leading medical technology company that develops and commercializes healthcare products.The company along with its subsidiaries is a provider of immunoassays, in-vitro diagnostics, and point of care (PoC) tests to entities involved in the life sciences,...

  • Infectious Disease
  • Diagnostics
  • In Vitro Diagnostic Reagent
  • Clinical Trial
  • Managed Care
  • United States
  • Medical Devices Sales

The global point of care diagnostics market is expected to reach US$ 70.89 Bn in 2027 from US$ 26.60 Bn in 2018. The market is estimated to grow with a CAGR of 11.8% from 2019-2027. The market for point of care diagnostics is expected to grow, owing to factors such as increasing incidences of infectious diseases, product launches and product...

  • Point Of Care Testing
  • World
  • Diabetes Prevalence
  • Cancer Incidence

Point of Care POC Infectious Disease Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025 Global POC Infectious Disease Diagnostics Market Size, Outlook and Growth Opportunities to 2025: By Technology( Lateral Flow, Agglutination Assays, Flow Through, Solid Phase, and Others), By Application( Tropical...

  • Infectious Disease
  • Managed Care
  • Diagnostics
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

Point Of Care (PoC) Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025 Global POC Disease Diagnostics Market Size, Outlook and Growth Opportunities to 2025: By Product( Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products,...

  • Diagnostics
  • Managed Care
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

Summary Mologic Ltd (Mologic) is a medical device company that designs, develops, manufactures and supplies in vitro diagnostic medical devices.The portfolio of companys products include bacterial vaginosis test kit, peritoneal dialysis test, lateral flow kit, desmosine ELISA kit and FMLP ELISA kit. It offers expertise...

  • Infectious Disease
  • Diagnostics
  • Clinical Trial
  • United Kingdom
  • Senegal
  • United States
  • West Africa
  • Hospital Admission
  • Medical Devices Sales